お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ

株式会社グローバルインフォメーション
市場調査レポート
商品コード
968748

プロテインAレジン市場 - 製品・マトリックスタイプ・アプリケーション (免疫沈降・抗体精製)・エンドユーザー・地域別:市場規模・シェア・展望・機会分析 (2020-2027年)

Protein A Resin Market, By Product, By Matrix Type, By Application (Immunoprecipitation, Antibody Purification), By End User, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

出版日: | 発行: Coherent Market Insights | ページ情報: 英文 163 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.77円
プロテインAレジン市場 - 製品・マトリックスタイプ・アプリケーション (免疫沈降・抗体精製)・エンドユーザー・地域別:市場規模・シェア・展望・機会分析 (2020-2027年)
出版日: 2020年09月28日
発行: Coherent Market Insights
ページ情報: 英文 163 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 目次
概要

プロテインAは細菌性タンパク質であり、免疫グロブリンGクラスの哺乳類抗体に高い親和性で結合する能力があります。プロテインGは、ヒト免疫グロブリンG(IgG)のすべてのサブクラスに結合するため、サブクラスが決定されていないポリクローナルまたはモノクローナルIgG抗体の精製に役立ちます。モノクローナル抗体は、「細胞の単一クローンによって産生される抗体」として定義されます。がん細胞に伝統的な薬物、毒素、または放射性物質を運ぶために使用できます。

モノクローナル抗体は、癌や関節リウマチなどの慢性疾患の管理において有望な結果を示しています。これらは不可欠であり、高分解能のためにバイオ医薬品業界全体で精製および分離材料として広く使用されています。天然型プロテインAは黄色ブドウ球菌から産生できますが、プロテインAは現在大腸菌で一般的に組換え体で産生されています。これらを使用したクロマトグラフィーには、溶媒抽出、結晶化、蒸留などの従来の手法に比べて、分離方法としていくつかの利点があります。

予測期間中にプロテインA樹脂市場の成長を妨げる主な要因は、モノクローナル抗体を精製する代替方法の増加です。

当レポートでは、世界のプロテインAレジン市場について調査し、市場の概要、市場に影響を及ぼす要因の分析、各セグメント・地域別の市場分析、主要企業のプロファイルなどを提供しています。

目次

第1章 調査目的・前提条件

  • 調査目的
  • 前提条件
  • 略語

第2章 市場概要

  • レポートの説明
    • 市場の定義と範囲
  • エグゼクティブサマリー
    • 市場内訳:製品別
    • 市場内訳:マトリックスタイプ別
    • 市場内訳:アプリケーション別
    • 市場内訳:エンドユーザー別
  • Coherent Opportunity Map (COM)

第3章 市場力学・規制・動向分析

  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
  • 影響分析
  • 主な発展
  • 規制シナリオ
  • PEST分析
  • COVID-19影響分析

第4章 世界のプロテインAレジン市場:製品別

  • イントロダクション
    • 市場シェア分析
    • 前年比成長分析
    • セグメント動向
  • 天然型プロテインA
    • イントロダクション
    • 市場規模と予測、および前年比成長率
    • セグメント動向
  • 組換え体プロテインA

第5章 世界のプロテインAレジン市場:マトリックスタイプ別

  • イントロダクション
    • 市場シェア分析
    • 前年比成長分析
    • セグメント動向
  • アガロースベース
    • イントロダクション
    • 市場規模と予測、および前年比成長率
  • ガラスまたはシリカベース
  • 有機ポリマーベース

第6章 世界のプロテインAレジン市場:アプリケーション別

  • イントロダクション
    • 市場シェア分析
    • 前年比成長分析
    • セグメント動向
  • 免疫沈降(IP)
    • イントロダクション
    • 市場規模と予測、および前年比成長率
  • 抗体精製

第7章 世界のプロテインAレジン市場:エンドユーザー別

  • イントロダクション
    • 市場シェア分析
    • 前年比成長分析
    • セグメント動向
  • バイオ医薬品メーカー
    • イントロダクション
    • 市場規模と予測、および前年比成長率
  • 臨床研究
  • 学術機関

第8章 世界のプロテインAレジン市場:地域別

  • イントロダクション
  • 北米
  • 米国
  • カナダ
  • 欧州
  • 英国
  • ドイツ
  • イタリア
  • フランス
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • 中国
  • インド
  • 日本
  • ASEAN
  • オーストラリア
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • ブラジル
  • メキシコ
  • アルゼンチン
  • その他ラテンアメリカ
  • 中東
  • GCC諸国
  • イスラエル
  • その他中東
  • アフリカ
  • 北アフリカ
  • 中央アフリカ
  • 南アフリカ

第9章 競合情勢

  • 企業プロファイル
    • GE Healthcare
    • Thermo Fisher Scientific
    • Repligen
    • Tosoh Bioscience
    • EMD Millipore
    • Novasep
    • GenScript Biotech Corporation
    • Purolite Life Sciences
    • Expedeon Ltd.
    • Other Players

第10章 セクション

目次

Title:
Protein A Resin Market, By Product (Natural Protein A, Recombinant Protein A), By Matrix Type (Agarose-based, Glass or Silica Based, Organic Polymer Based), By Application (Immunoprecipitation (IP), Antibody Purification), By End User (Biopharmaceutical Manufacturers, Clinical Research Laboratories, Academic Institutes), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027.

Protein A is a bacterial protein, which has capacity to bind mammalian antibodies of class immunoglobulin G with great affinity. Protein G binds to all subclasses of human immunoglobulin G (IgG) makes it useful for purifying polyclonal or monoclonal IgG antibodies whose subclasses have not been determined. Monoclonal antibodies are defined as 'an antibody produced by a single clone of cells'. It can be used to carry drugs, toxins, or radioactive substances traditional to cancer cells. Monoclonal antibodies have been showing promising results in the management of chronic diseases such as cancers and rheumatoid arthritis. These are essential and are broadly used as purification and separation materials due to high resolution, across the biopharmaceutical industry. Natural protein A can be produced from Staphylococcus aureus, though protein A is now commonly produced recombinant in Escherichia coli. Chromatography with these has several advantages as a separation method, over conventional techniques such as solvent extraction, crystallization, and distillation.

Restraints of the Global Protein A Resin Market

Major factors hampering the growth of the protein A resin market during the forecast period constitutes of rise in alternate methods for purification of monoclonal antibodies.

Key features of the study:

  • This report provides in-depth analysis of the global protein A resin market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2020-2027), considering 2019, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
  • It profiles leading players in the global protein A resin market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include GE Healthcare, Thermo Fisher Scientific, Repligen, Tosoh Bioscience, EMD Millipore, Novasep, GenScript Biotech Corporation, Purolite Life Sciences, and Expedeon Ltd.
  • Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global protein A resin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

  • Global Protein A Resin Market, By Product:
    • Natural Protein A
    • Recombinant Protein A
  • Global Protein A Resin Market, By Matrix Type:
    • Agarose-based
    • Glass or Silica Based
    • Organic Polymer Based
  • Global Protein A Resin Market, By Application:
    • Immunoprecipitation (IP)
    • Antibody Purification
  • Global Protein A Resin Market, By End User:
    • Biopharmaceutical Manufacturers
    • Clinical Research Laboratories
    • Academic Institutes
  • Global Protein A Resin Market, By Geography:
    • North America
  • By Product
    • Natural Protein A
    • Recombinant Protein A
  • By Matrix Type
    • Agarose-based
    • Glass or Silica Based
    • Organic Polymer Based
  • By Application
    • Immunoprecipitation (IP)
    • Antibody Purification
  • By End User
    • Biopharmaceutical Manufacturers
    • Clinical Research Laboratories
    • Academic Institutes
  • By Country:
    • U.S.
    • Canada
    • Europe
  • By Product
    • Natural Protein A
    • Recombinant Protein A
  • By Matrix Type
    • Agarose-based
    • Glass or Silica Based
    • Organic Polymer Based
  • By Application
    • Immunoprecipitation (IP)
    • Antibody Purification
  • By End User
    • Biopharmaceutical Manufacturers
    • Clinical Research Laboratories
    • Academic Institutes
  • By Country:
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
  • By Product
    • Natural Protein A
    • Recombinant Protein A
  • By Matrix Type
    • Agarose-based
    • Glass or Silica Based
    • Organic Polymer Based
  • By Application
    • Immunoprecipitation (IP)
    • Antibody Purification
  • By End User
    • Biopharmaceutical Manufacturers
    • Clinical Research Laboratories
    • Academic Institutes
  • By Country:
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
    • Latin America
  • By Product
    • Natural Protein A
    • Recombinant Protein A
  • By Matrix Type
    • Agarose-based
    • Glass or Silica Based
    • Organic Polymer Based
  • By Application
    • Immunoprecipitation (IP)
    • Antibody Purification
  • By End User
    • Biopharmaceutical Manufacturers
    • Clinical Research Laboratories
    • Academic Institutes
  • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Middle East:
  • By Product
    • Natural Protein A
    • Recombinant Protein A
  • By Matrix Type
    • Agarose-based
    • Glass or Silica Based
    • Organic Polymer Based
  • By Application
    • Immunoprecipitation (IP)
    • Antibody Purification
  • By End User
    • Biopharmaceutical Manufacturers
    • Clinical Research Laboratories
    • Academic Institutes
  • By Country:
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
  • By Product
    • Natural Protein A
    • Recombinant Protein A
  • By Matrix Type
    • Agarose-based
    • Glass or Silica Based
    • Organic Polymer Based
  • By Application
    • Immunoprecipitation (IP)
    • Antibody Purification
  • By End User
    • Biopharmaceutical Manufacturers
    • Clinical Research Laboratories
    • Academic Institutes
  • By Country/Region:
    • Central Africa
    • South Africa
    • North Africa
  • Company Profiles
    • GE Healthcare*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Key Strategies
  • Recent Developments
    • Thermo Fisher Scientific
    • Repligen
    • Tosoh Bioscience
    • EMD Millipore
    • Novasep
    • GenScript Biotech Corporation
    • Purolite Life Sciences
    • Expedeon Ltd.
    • Other Players

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

    • Research Objectives
    • Assumptions
    • Abbreviations

2. Market Purview

    • Report Description
  • Market Definition and Scope
    • Executive Summary
  • Market Snippet, By Product
  • Market Snippet, By Matrix Type
  • Market Snippet, By Application
  • Market Snippet, By End User
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
    • Impact Analysis
    • Key Developments
    • Regulatory Scenario
    • PEST Analysis
    • COVID-19 Impact Analysis

4. Global Protein A Resin Market, By Product, 2019 - 2027 (US$ Mn)

    • Introduction
  • Market Share Analysis, 2019 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • Natural Protein A
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Segment Trends
    • Recombinant Protein A
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Segment Trends

5. Global Protein A Resin Market, By Matrix Type, 2019 - 2027 (US$ Mn)

    • Introduction
  • Market Share Analysis, 2019 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • Agarose-based
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Glass or Silica Based
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Organic Polymer Based
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

6. Global Protein A Resin Market, By Application, 2019 - 2027 (US$ Mn)

    • Introduction
  • Market Share Analysis, 2019 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • Immunoprecipitation (IP)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Antibody Purification
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

7. Global Protein A Resin Market, By End User, 2019 - 2027 (US$ Mn)

    • Introduction
  • Market Share Analysis, 2019 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • Biopharmaceutical Manufacturers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Clinical Research Laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Academic Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

8. Global Protein A Resin Market, By Regions, 2019 - 2027 (US$ Mn)

    • Introduction
  • Market Share Analysis, 2019 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • U.S.
    • Canada
    • Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
    • Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

    • Company Profiles
  • GE Healthcare
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Thermo Fisher Scientific
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Repligen
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Tosoh Bioscience
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • EMD Millipore
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Novasep
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • GenScript Biotech Corporation
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Purolite Life Sciences
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Expedeon Ltd.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Other Players
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

10. Section

    • References
    • Research Methodology
    • About us and Sales Contact
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.